ContextVision Sees Strong Sales, Major Progress Within R&D in Q4 2017
STOCKHOLM - February 22, 2018 - ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, reports a sustainable business and progress of the ambitious AI-based research and development program. The company has a strong market position and sales ended at 22,5 MSEK in Q4 2017, compared to 24,9 MSEK the previous year. The difference is explained by the extraordinary order for field upgrades within MRI during 2016. ContextVision made up for most of this difference on a full-year basis and sales ended at 80,5 MSEK versus 81,9 MSEK last